<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00968578</url>
  </required_header>
  <id_info>
    <org_study_id>H-C-2008-134</org_study_id>
    <secondary_id>2009-41-3786</secondary_id>
    <nct_id>NCT00968578</nct_id>
  </id_info>
  <brief_title>Effects of Methylprednisolone After Total Knee Arthroplasty</brief_title>
  <official_title>Effects of Pre-operative Methylprednisolone (125mg iv) After Total Knee Arthroplasty: A Prospective, Randomized, Double-blind, Placebo-controlled Trail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lundbeck Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hvidovre University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare the effects of pre-operative methylprednisolone (125mg&#xD;
      iv) versus placebo on postoperative outcome after knee arthroplasty.&#xD;
&#xD;
      The hypothesis is that pre-operative methylprednisolone (125mg iv) will reduce pain and&#xD;
      improve outcome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In spite of being one of the last century's most successful surgical procedures in treatment&#xD;
      of advanced osteoarthritis total knee arthroplasty is still associated with postoperative&#xD;
      pain and delayed rehabilitation. We therefore decided to evaluate the effects of&#xD;
      pre-operative methylprednisolone (125mg iv) versus placebo on postoperative outcome in a well&#xD;
      defined fast-track setup after knee arthroplasty.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>48 hours + follow up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting (PONV)</measure>
    <time_frame>48 hours + follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleeping quality</measure>
    <time_frame>48 hours + follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory response</measure>
    <time_frame>48 hours + follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Additional analgetics, antinausea agents and sleeping medicine</measure>
    <time_frame>48 hours + follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time in hospital</measure>
    <time_frame>Until discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>48 hours + follow up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Postoperative Nausea and Vomiting</condition>
  <condition>Sleeping Quality</condition>
  <condition>Fatigue</condition>
  <condition>Inflammatory Response</condition>
  <arm_group>
    <arm_group_label>Methylprednisolone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Methylprednisolone 125 mg iv pre-operatively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline iv pre-operatively in equivalent volume (placebo)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylprednisolone</intervention_name>
    <description>Methylprednisolone 125 mg iv pre-operatively</description>
    <arm_group_label>Methylprednisolone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Saline iv pre-operatively in equivalent volume (placebo)</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elective total knee arthroplasty&#xD;
&#xD;
          -  Able to speak and understand danish&#xD;
&#xD;
          -  Able to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Alcohol or medical abuse&#xD;
&#xD;
          -  Allergies to local anesthetics or methylprednisolone&#xD;
&#xD;
          -  Age &lt; 18 years&#xD;
&#xD;
          -  Daily use of opioids or glucocorticoids&#xD;
&#xD;
          -  Pregnancy or breastfeeding (fertile women)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hvidovre University Hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Hvidovre</state>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <study_first_submitted>August 28, 2009</study_first_submitted>
  <study_first_submitted_qc>August 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2009</study_first_posted>
  <last_update_submitted>September 25, 2012</last_update_submitted>
  <last_update_submitted_qc>September 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hvidovre University Hospital</investigator_affiliation>
    <investigator_full_name>Troels Haxholdt Lunn</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Knee arthroplasty</keyword>
  <keyword>Methylprednisolone</keyword>
  <keyword>Post-operative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Acetate</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

